INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 443m ago
HOUSE PTR43m ago
SEC 13F43m ago
ROBINHOOD CHAIN43m ago
Public company

Twist Bioscience Corp

TWSTCIK 0001581280

EDGAR filingsOpen in network
Price$120.79
1 year+283.2%
Disclosed transactions6
Buys / sells0 / 6
Max Insider Score42
Connections with evidence9

TWST · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
42
LM
Leproust Emily M.Director, Chief Executive Officer
TWSTTwist Bioscience Corp
Open-market sale
SELL$619K
4,573 sh
Nov 3, 2026Nov 5, 2026

Verified connections

  • ← Holds over 5% ofevidence
    FMR LLC14.4% of class · Schedule 13G · Nov 4, 2026
  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Leproust Emily M.Officer, Director · Form 144 · Nov 2, 2026
  • ← Insider ofevidence
    Werner Robert F.Officer · Form 144 · Nov 2, 2026
  • ← Insider ofevidence
traded Nov 3, 2026
+2d
SEC FORM 4

Evidence

39
CD
Cho DennisSee Remarks
TWSTTwist Bioscience Corp
Open-market sale
SELL$128K
949 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

42
FJ
Finn Patrick JohnPresident and COO
TWSTTwist Bioscience Corp
Open-market sale
SELL$347K
2,565 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

39
GP
Green PaulaSVP of Human Resources
TWSTTwist Bioscience Corp
Open-market sale
SELL$136K
1,007 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

36
WF
Werner Robert F.Chief Accounting Officer
TWSTTwist Bioscience Corp
Open-market sale
SELL$20K
148 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

36
ARK Investment Management LLC13F filer
TWSTTwist Bioscience Corp
TRIM
SELL$184.46M
1.79M sh
Not disclosedAug 14, 2026quarterlySEC 13F

Evidence

Green Paula
Officer · Form 144 · Nov 2, 2026
  • ← Insider ofevidence
    Finn Patrick JohnOfficer · Form 144 · Nov 2, 2026
  • ← Insider ofevidence
    Cho DennisOfficer · Form 144 · Nov 2, 2026
  • ← Lobbied forevidence
    IPOLICY SOLUTIONSLDA Q2 2026 second quarter · Science/technology, Trade · Aug 26, 2026
  • ← Holdsevidence
    ARK Investment Management LLC3.0% of reported portfolio · Aug 14, 2026

    • Lobbying

    $165K reported · de-duplicated
    2026 Q2 $83K via firms2026 Q1 $83K via firms
    • IPOLICY SOLUTIONS$83K2026 Q1 · posted Aug 26, 2026 · Science/technology, Trade
    • IPOLICY SOLUTIONS$83K2026 Q2 · posted Aug 26, 2026 · Science/technology, Trade

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.

    Planned sales and 5% stakes

    Form 144, 13D and 13G
    • FMFMR LLCPassive holder · crossed on Sep 30, 2026 · 9.54M shares14.4% of class13G amendment · filed Nov 5, 2026
    • CDCho DennisOfficer · sale around Nov 3, 2026 · 949 shares$128KForm 144 · filed Nov 3, 2026
    • FJFinn Patrick JohnOfficer · sale around Nov 3, 2026 · 2,565 shares$347KForm 144 · filed Nov 3, 2026
    • GPGreen PaulaOfficer · sale around Nov 3, 2026 · 1,007 shares$136KForm 144 · filed Nov 3, 2026
    • LMLeproust Emily M.Officer, Director · sale around Nov 3, 2026 · 4,573 shares$619KForm 144 · filed Nov 3, 2026
    • WFWERNER ROBERT F.Officer · sale around Nov 3, 2026 · 148 shares$20KForm 144 · filed Nov 3, 2026